phrykt

Sotera Health Co (SHC): who owns it and who trades it

As of Nov 16, 2026, SHC insiders reported 12 open-market sales worth $1.2B and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Warburg Pincus (Cayman) XI, L.P. (Director), with $290M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Sotera Health

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SHC

315 funds and institutions reported SHC shares worth $5.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Sessa Capital IM, L.P. with 9.5%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

Sessa Capital IM, L.P.9.5%
Darsana Capital Partners LP9.5%
BlackRock, Inc.8.5%
Sculptor Capital LP8.4%
Sachem Head Capital Management LP5.5%
Vanguard Capital Management LLC4.3%
Vanguard Portfolio Management LLC4.2%
AQR Capital Management LLC3.8%
T. Rowe Price Investment Management, Inc.3.7%
Jupiter Topco LLC2.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Sessa Capital IM, L.P.27.05M9.49%$480M+17%
Darsana Capital Partners LP27.00M9.47%$479M+4%
BlackRock, Inc.24.15M8.47%$429M+16%
Sculptor Capital LP24.00M8.42%$426M+11%
Sachem Head Capital Management LP15.56M5.46%$276M+34%
Vanguard Capital Management LLC12.17M4.27%$216M+13%
Vanguard Portfolio Management LLC11.95M4.19%$212M+13%
AQR Capital Management LLC10.73M3.76%$186M+60%
T. Rowe Price Investment Management, Inc.10.52M3.69%$187M+15%
Jupiter Topco LLC8.40M2.95%$149M–
State Street Corp8.32M2.92%$148M+19%
FMR LLC (Fidelity)6.17M2.16%$110M–
Two Seas Capital LP5.84M2.05%$104M-3%
Voss Capital, LP5.83M2.04%$103M+20%
Dimensional Fund Advisors LP5.80M2.03%$103M+5%
Geode Capital Management, LLC5.22M1.83%$92.7M+13%
Irenic Capital Management LP5.14M1.80%$91.3M+18%
DME Capital Management, LP4.14M1.45%$73.4M+100%
Lakewood Capital Management, LP3.98M1.40%$70.6M-3%
Norges Bank3.51M1.23%$62.3M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, SHC insiders reported $0 of open-market purchases and $1.2B of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$1.2B
12 trades, 8 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 17, 2026
Filed Aug 19, 2026

Purchases and sales by month

$483M$483MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 17, 2026Michael B. Petras Jr.ChairSale294,515$18.50$5.4MForm 4
Aug 17, 2026Michael B. Petras Jr.ChairSale850,000$18.50$15.7MForm 4
Aug 7, 2026Michael P RutzPresidentSale150,000$18.84$2.8MForm 4
May 13, 2026Warburg Pincus (Cayman) XI, L.P. +7DirectorSale19.10M$15.17$290MForm 4
May 13, 2026Gtcr Fund Xi/C Lp +4DirectorSale12.74M$15.17$193MForm 4
Mar 6, 2026Warburg Pincus Partners GP LLC +7DirectorSale15.00M$15.27$229MForm 4
Mar 6, 2026Gtcr Co-Invest Xi Lp +4DirectorSale10.00M$15.27$153MForm 4
Dec 8, 2025Michael B. Petras Jr.CEOSale315,896$16.45$5.2MForm 4
Dec 8, 2025Michael B. Petras Jr.CEOSale394,861$16.45$6.5MForm 4
Dec 8, 2025Michael B. Petras Jr.CEOSale39,243$16.45$646KForm 4
Dec 3, 2025Warburg Pincus Llc +7DirectorSale9.72M$16.33$159MForm 4
Dec 3, 2025Gtcr Fund Xi/A Lp +4DirectorSale6.48M$16.33$106MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Warburg Pincus (Cayman) XI, L.P.Director, 10% owner–$290MMay 13, 2026
Warburg Pincus Partners GP LLCDirector, 10% owner–$229MMar 6, 2026
Gtcr Fund Xi/C LpDirector, 10% owner–$193MMay 13, 2026
Warburg Pincus LlcDirector, 10% owner–$159MDec 3, 2025
Gtcr Co-Invest Xi LpDirector, 10% owner–$153MMar 6, 2026
Gtcr Fund Xi/A LpDirector, 10% owner–$106MDec 3, 2025
Michael B. Petras Jr.Chairman & CEO, Director–$33.5MAug 17, 2026
Michael P RutzPresident of Sterigenics–$2.8MAug 7, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SHC short interest

Moderate short interest. 5.8% of SHC shares are sold short: about 1 share in 17. Over the last 12 reports the number of shares short went down 17%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 16.44M SHC shares were sold short, 5.8% of the shares outstanding, up 2.2% from the report before. At the average daily volume of 2.18M shares, buying them all back would take about 7.5 trading days (days to cover).

Shares short, % of all shares

5.76%May 15Oct 307.32%

Days to cover

7.5May 15Oct 309.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202616.44M5.76%+2%2.18M7.5
Oct 15, 202616.09M5.64%+9%1.91M8.4
Sep 30, 202614.75M5.17%+20%2.18M6.8
Sep 15, 202612.27M4.30%+3%1.69M7.2
Aug 31, 202611.96M4.19%-1%2.61M4.6
Aug 14, 202612.12M4.25%-16%2.86M4.2
Jul 31, 202614.38M5.04%-9%3.00M4.8
Jul 15, 202615.84M5.55%-1%2.90M5.5
Jun 30, 202616.02M5.62%-9%2.68M6.0
Jun 15, 202617.63M6.18%-6%2.49M7.1
May 29, 202618.84M6.61%-4%2.70M7.0
May 15, 202619.70M6.91%+38%5.98M3.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Sotera Health company events

Sotera Health filed 12 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Aug 14, 2026LeadershipJames C. Neary notified the Board of Directors of Sotera Health Company of his resignation as a Class I director, effective August 13, 2026. Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. May 22, 2026VoteReported shareholder vote results. Filing
  5. May 20, 2026AgreementSotera Health Company, Sotera Health Holdings, LLC, certain subsidiaries of the Company, each 2026 Refinancing Term Lender and JPMorgan Chase Bank, N.A., as first lien Administrative Agent entered into Amendment No. 7 to the First Lien Credit Agreement dated as of December 13, 2019, by and among… Filing
  6. May 13, 2026AnnouncementA description of the terms of the Stockholders Agreement is found under the caption “Certain Relationships and Related Party Transactions—Stockholders Agreement” in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026 and… Filing
  7. May 5, 2026LeadershipIn accordance with the Company’s executive succession plans, on May 5, 2026, the Company announced a leadership transition pursuant to which, on May 1, 2026, the Board of Directors, at the recommendation of the Nominating and Corporate Governance Committee, appointed Alton Shader to serve as Chief… Filing
  8. Mar 16, 2026LeadershipAs a result of a reduction in the number of directors that certain stockholders are entitled to designate for election to the Board of Directors of Sotera Health Company, Constantine S. Mihas notified the Board of his intention to resign as a Class I director, effective March 16, 2026. Filing
  9. Mar 6, 2026AnnouncementSotera Health Company, certain stockholders named in Schedule 2 thereto and Wells Fargo Securities, LLC, as underwriter, entered into an underwriting agreement relating to the sale of 25,000,000 shares of the Company’s common stock, par value $0.01 per share by the Selling Stockholders, at a price… Filing
  10. Feb 24, 2026LeadershipAlex Dimitrief, Senior Vice President and General Counsel of the Company, provided notice to the Company that he will retire on March 31, 2026. Filing
  11. Feb 5, 2026LeadershipThe Board of Directors of Sotera Health Company increased the size of the Board from eleven directors to twelve directors and appointed Richard G. Kyle as a Class III director of the Board, effective immediately. Filing
  12. Jan 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Sotera Health financials

Famous investors that hold SHC

5 of the 50 well-known investors we track reported holding SHC in their latest 13F filing. The largest position is David Einhorn's, worth $59.9M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
David Einhorn · Greenlight Capital (DME)Q3 20263.24M$59.9M1.7%-22%
Paul Tudor Jones · Tudor Investment CorpQ3 2026985,120$18.2M0.1%No change
Steve Cohen · Point72 Asset ManagementQ3 2026974,739$18M0.0%New
Israel Englander · Millennium ManagementQ3 2026786,153$14.5M0.0%-59%
Ken Griffin · Citadel AdvisorsQ3 2026280,479$5.2M0.0%-86%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named SHC in the last 120 days.

FiledHolderFormStake
Oct 30, 2026Vanguard Capital Management13G5.1%
Oct 30, 2026Vanguard Capital Management13G5.1%
Oct 9, 2026Sachem Head Capital Management LP13G/A0.0%
Oct 9, 2026Sachem Head Capital Management LP13G/A0.0%

Questions about Sotera Health Co (SHC) stock

Who owns the most SHC stock?

The largest reported owner of Sotera Health Co (SHC) is Sessa Capital IM, L.P., with 9.5% of the company. In total, 315 funds and institutions reported holding SHC at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are SHC insiders buying or selling?

In the last 12 months, SHC insiders reported no open-market purchases and 12 sales worth $1.2B. The latest trade was on Aug 17, 2026. See every trade.

What is the short interest in SHC?

As of Oct 30, 2026, 16.44M SHC shares were sold short, 5.8% of the shares outstanding, up 2.2% from the report before. At the average daily volume of 2.18M shares, buying them all back would take about 7.5 trading days (days to cover). See the history.

Which famous investors hold SHC?

5 of the 50 well-known investors we track reported SHC in their latest 13F filing, including David Einhorn, Paul Tudor Jones, Steve Cohen. The largest position is worth $59.9M. See all holders.

Executive pay

Sotera Health's chief executive was paid a total of $10.7M for the year ended Dec 31, 2025, up 3% from $10.4M the year before. In the last 12 months, Sotera Health's executives and directors bought no stock on the open market and sold $36.3M.

Chief executive, total pay$10.7MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$16.7MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.6MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.